PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-May-2021 Amylyx Pharmaceuticals Presents Trial Design of Global Phase 3 PHOENIX Study of AMX0035 in ALS at the European Network to Cure ALS (ENCALS) Meeting 2021 Businesswire
12-May-2021 Global Exosome Research Products Industry (2020 to 2027) - Market Trajectory & Analytics - ResearchAndMarkets.com Businesswire
12-May-2021 Worldwide Homogenizers Industry to 2025 - Reforms in Milk Production in the EU are Driving Growth - ResearchAndMarkets.com Businesswire
12-May-2021 Global Pharmaceutical Lipids Market is projected to rise at a considerable pace between 2021 and 2031 MARKITWIRED
12-May-2021 ADC Therapeutics Announces Online Publication of LOTIS-2 Results in The Lancet Oncology Businesswire
12-May-2021 NephroDI Therapeutics Lands Financing to Develop a Treatment for Nephrogenic Diabetes Insipidus, an Orphan Disease Businesswire
12-May-2021 Insights on the Hydrazine Hydrate Global Market to 2026 - Featuring Arkema Group, Arrow Fine Chemicals and Lonza Among Others - ResearchAndMarkets.com Businesswire
12-May-2021 Shifa Launches with Seed Financing to Address Cardiovascular Disease by Developing Orally Bioavailable Drugs for the Treatment of Dyslipidemia Businesswire
12-May-2021 Peroxitech Therapeutics Secures Seed Financing to Advance New Treatment of Acute Lung Injury Businesswire
12-May-2021 Results of Biomarck Phase II Study of BIO-11006 in Patients with ARDS to be Presented at the 2021 ATS Annual Meeting Businesswire
12-May-2021 Global Hdl Cholesterol Kits Market Report, History And Forecast 2019-2029, Breakdown Data By Manufacturers, Key Regions, Types And Application MARKITWIRED
12-May-2021 Apyx Medical Corporation Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Outlook Businesswire
12-May-2021 Moderna Announces New Supply Agreement with Australia for 25 Million Doses of its COVID-19 Vaccine Businesswire
12-May-2021 Labcorp Announces Proposed Sale of Senior Notes Businesswire
12-May-2021 Xontogeny Announces Launch of Several New Early-Stage Portfolio Companies Businesswire
12-May-2021 Xontogeny Announces Launch of Several New Early-Stage Portfolio Companies Businesswire
12-May-2021 UK Manufacturing Facility & Phase III Trial Updates From Northwest Biotherapeutics (OTCQB: NWBO) Northwest Biotherapeutics
12-May-2021 Vivet Therapeutics Announces Multiple Projects Update, Including New VTX-803 Preclinical data To Be Presented At 2021 American Society Of Gene And Cell Therapy Annual Meeting Vivet Therapeutics
12-May-2021 Bayer’s finerenone meets primary endpoint in Phase III FIGARO-DKD cardiovascular outcomes study in patients with chronic kidney disease and type 2 diabetes Bayer
12-May-2021 Xilio Therapeutics Presents Preclinical Tumor-Selective Activity and Tolerability Data for XTX101 at Frontiers in Cancer Immunotherapy Virtual Symposium Businesswire